Bone health in phenylketonuria: a systematic review and meta-analysis

详细信息    查看全文

• 作者：Serwet Demirdas ; Katie E Coakley ; Peter H Bisschop…
• 关键词：Phenylketonuria ; PKU ; Bone mineral density ; BMD ; Bone turnover markers ; Phenylalanine ; Osteopenia ; Osteoporosis ; Meta ; analysis ; Systematic review
• 刊名：Orphanet Journal of Rare Diseases
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：10
• 期：1
• 全文大小：3,482 KB
• 参考文献：1. Blau, N, Belanger-Quintana, A, Demirkol, M, Feillet, F, Giovannini, M, MacDonald, A (2010) Management of phenylketonuria in Europe: survey results from 19 countries. Mol Genet Metab 99: pp. 109-15 CrossRef
  2. Spronsen, FJ, Burgard, P (2008) The truth of treating patients with phenylketonuria after childhood: the need for a new guideline. J Inherit Metab Dis 31: pp. 673-9 CrossRef
  3. Demirkol, M, Gizewska, M, Giovannini, M, Walter, J (2011) Follow up of phenylketonuria patients. Mol Genet Metab 104: pp. S31-9 CrossRef
  4. Robert, M, Rocha, JC, Rijn, M, Ahring, K, Belanger-Quintana, A, MacDonald, A (2013) Micronutrient status in phenylketonuria. Mol Genet Metab 110(Suppl): pp. S6-17 CrossRef
  5. Camp, KM, Parisi, MA, Acosta, PB, Berry, GT, Bilder, DA, Blau, N (2014) Phenylketonuria scientific review conference: state of the science and future research needs. Mol Genet Metab 112: pp. 87-122 CrossRef
  6. Blau, N, Spronsen, FJ, Levy, HL (2010) Phenylketonuria. Lancet 376: pp. 1417-27 CrossRef
  7. Harding, CO, Blau, N (2010) Advances and challenges in phenylketonuria. J Inherit Metab Dis 33: pp. 645-8 CrossRef
  8. Giovannini, M, Verduci, E, Salvatici, E, Paci, S, Riva, E (2012) Phenylketonuria: nutritional advances and challenges. Nutr Metab (Lond) 9: pp. 7 CrossRef
  9. Feinberg, SB, Fisch, RO (1962) Roentgenologic findings in growing long bones in phenylketonuria. Preliminary study.. Radiology 78: pp. 394-8 CrossRef
  10. Murdoch, MM, Holman, GH (1964) Roentgenologic bone changes in phenylketonuria. Relation to dietary phenylalanine and serum alkaline phosphatase. Am J Dis Child 107: pp. 523-32 CrossRef
  11. Porta, F, Spada, M, Lala, R, Mussa, A (2008) Phalangeal quantitative ultrasound in children with phenylketonuria: a pilot study. Ultrasound Med Biol 34: pp. 1049-52 CrossRef
  12. Schwahn, B, Mokov, E, Scheidhauer, K, Lettgen, B, Sch?nau, E (1998) Decreased trabecular bone mineral density in patients with phenylketonuria measured by peripheral quantitative computed tomography. Acta Paediatr 87: pp. 61-3 CrossRef
  13. Adamczyk, P, Morawiec-Knysak, A, Pludowski, P, Banaszak, B, Karpe, J, Pluskiewicz, W (2011) Bone metabolism and the muscle-bone relationship in children, adolescents and young adults with phenylketonuria. J Bone Miner Metab 29: pp. 236-44 CrossRef
  14. Groot, MJ, Hoeksma, M, Rijn, M, Slart, RH, Spronsen, FJ (2012) Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients. Mol Genet Metab 105: pp. 566-70 CrossRef
  15. Lage, S, Bueno, M, Andrade, F, Prieto, JA, Delgado, C, Legarda, M (2010) Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density. J Inherit Metab Dis 33: pp. 363-71 CrossRef
  16. Zeman, J, Bayer, M, Stepan, J (1999) Bone mineral density in patients with phenylketonuria. Acta Paediatr 88: pp. 1348-51 CrossRef
  17. Allen, JR, Humphries, IR, Waters, DL, Roberts, DC, Lipson, AH, H
• 刊物主题：Medicine/Public Health, general; Pharmacology/Toxicology; Medicinal Chemistry;
• 出版者：BioMed Central
• ISSN：1750-1172

文摘

Patients with Phenylketonuria (PKU) reportedly have decreased bone mineral density (BMD). The primary aim of this study was to perform a systematic review and meta-analysis to determine the extent and significance of low BMD in early treated patients with PKU. Secondary aims were to assess other bone status indicators including bone turnover markers (BTM) and to define areas for future research. Two research teams (Amsterdam, Netherlands and Atlanta, USA) performed literature searches for articles reporting data on BMD, osteopenia and osteoporosis, BTM or other bone indicators in patients with PKU. Included articles were compared between research teams and assessed for quality and risk of bias. A total of 13 unique articles were included; 11/13 articles reported BMD including a total of 360 patients. Ten out of 11 articles found BMD was significantly lower in patients with PKU. Meta-analyses for total BMD (TBMD; 3 studies; n--33), lumbar spine BMD (LBMD; 7 studies; n--47), and femoral neck BMD (FBMD; 2 studies; n--8) Z-scores were performed. Overall effect sizes were: TBMD ?.45 (95% CI ?.61, ?.28); LBMD ?.70 (95% CI ?.82, ?.57); FBMD ?.96 (95% CI ?.42, ?.49). Definitions of osteopenia and osteoporosis were highly heterogeneous between studies and did not align with World Health Organization standards and the International Society for Clinical Densitometry positions on BMD measurement. Despite individual study findings of low BMD indicating higher risk of osteoporosis, pooled available data suggest reduction in BMD is not clinically important when using standard definitions of low BMD. Results from studies evaluating BTM are inconclusive. Phenylalanine concentration, vitamin D, PTH, and nutrient intake do not correlate with BMD or BTM. We recommend forthcoming studies use standard definitions of low BMD to determine clinical implications of BMD Z-scores below 0, explore cause of low BMD in the subset of patients with low BMD for chronological age (Z-score-??2) and assess fracture risk in patients with PKU.